Public Consultation on the Post-market Review of Pharmaceutical Benefits Scheme Medicines Used to Treat Asthma in Children
Page last updated: 19 May 2014
Draft Report
Submissions on the draft Report for the Post-market Review of PBS Medicines Used to
Treat Asthma in Children have closed. Thank you to everyone who made a submission.
The Final Report and submissions will be submitted to the PBAC for consideration at
the July 2014 PBAC Meeting.
Stakeholder Forum Outcome
The Stakeholder Forum was held in Canberra on 18 November 2013 for the Post-market Review of PBS Medicines Used to Treat Asthma in Children.
The Forum provided a further opportunity for stakeholders to contribute the Review. The Forum summary is now available for viewing:
Public Submissions
The Call for Submissions closed on 2 April 2013. The Department appreciates the contribution of all organisations and individuals who made a submission.
Unless otherwise requested, submissions addressing the Post-market Review of PBS Medicines Used to Treat Asthma in Children Terms of Reference have been published below.
The Department of Health has not published submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.
Responsibility for copyright in submissions resides with the author(s), not with the Department of Health.
All submissions have been converted to Portable Document Format (PDF) and Hyper Text Markup Language (HTML) versions for publication and may have a different appearance to the document that was submitted.
More information is available at Post-market Review of Pharmaceutical Benefits Scheme Medicines to Treat Asthma in Children. If you have difficulty accessing the information provided and need further assistance, please send an email to the PBS Post-market inbox.
Disclaimer
- The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
- The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
- The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquires and assessments about those matters or seek independent advice.
- Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.
- The Commonwealth reserves the right not to publish a submission or part of a submission that it considers defamatory or otherwise inappropriate for publication.
Table of Submissions
|
Submission |
Author Name |
Document link |
Date Received |
|---|---|---|---|
|
1 |
Individual Professional |
Not for publication |
22/02/2013 |
|
2 |
Royal Australasian College of Physicians |
26/02/2013 |
|
|
3 |
Australian Medical Association |
12/03/2013 |
|
|
4 |
Thoracic Society of Australia and New Zealand |
12/03/2013 |
|
|
5 |
Industry Organisation |
Not for publication |
27/03/2013 |
|
6 |
Individual Professional |
22/03/2013 |
|
|
7 |
Australasian Society of Clinical Immunology and Allergy (ASCIA) |
30/03/2013 |
|
|
8 |
Australasian College for Emergency Medicine (ACEM) |
02/04/2013 |
|
|
9 |
GlaxoSmithKline Australia |
02/04/2013 |
|
|
10 |
Medicines Australia |
02/04/2013 |
|
|
11 |
Consumers Health Forum of Australia |
02/04/2013 |
|
|
12 |
Dr David Herd |
19/03/2013 |
|
|
13 |
National Asthma Council Australia |
02/04/2013 |
|
|
14 |
AstraZeneca |
02/04/2013 |
|
|
15 |
NPS MedicineWise |
02/04/2013 |
|
|
16 |
The Pharmacy Guild of Australia |
02/04/2013 |
